Storys aus Essen
-
Sprache:
Englisch
- Medien:
- Zeitraum:
- Zeitraum:Gesamt
- mehr
Evonik and Phathom Pharmaceuticals partner to produce novel acid-blocker vonoprazan
Essen, Germany (ots/PRNewswire) - - Evonik to produce commercial quantities of the drug substance vonoprazan for use in VOQUEZNA™ TRIPLE PAK™ and DUAL PAK™, and other products containing vonoprazan - Supply security through production at sites in Europe and North America - Agreement strengthens Evonik's track record as leading contract development and ...
mehr- 3
Asia's only selected "World's Best Christmas Market"
mehr Gerresheimer Reports Strong Second Quarter
- Revenues up 7.2% on the prior-year quarter to EUR 356.5m - Adjusted EBITDA at EUR 74.2m in second quarter of 2019 (Q2 2018: EUR 71.1m), excluding EUR 26.2m from derecognition of contingent purchase price components in connection with Sensile Medical acquisition - Revenue guidance confirmed without change; guidance on adjusted EBITDA at constant exchange rates for the financial year 2019 approximately EUR 295m (plus ...
mehrEANS-Adhoc: MEDION AG / Conclusion of a domination and profit and loss transfer agreement - Determination of a compensation of EUR 13.00 per share
issuer: MEDION AG Am Zehnthof 77 D-45307 Essen phone: +49(0)201 83836500 FAX: +49(0)201 83836510 mail: aktie@medion.com WWW: http://www.medion.com sector: Technology ISIN: DE0006605009 indexes: stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin, Hamburg, Stuttgart, Düsseldorf, Hannover, ...
mehrEANS-Adhoc: MEDION AG / Company outlook 2011
issuer: MEDION AG Am Zehnthof 77 D-45307 Essen phone: +49(0)201 83836500 FAX: +49(0)201 83836510 mail: aktie@medion.com WWW: http://www.medion.com sector: Technology ISIN: DE0006605009 indexes: stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin, Hamburg, Stuttgart, Düsseldorf, Hannover, München language: English ...
mehr